news 3D printed microneedle vaccine shows promise in animals 19 October 2021 | By Victoria Rees (Drug Target Review) Researchers have shown that a new microneedle vaccine patch was 10 times stronger at generating an immune response in animals than a subcutaneous injection.
news Two COVID-19 vaccines show safety and strong immunity in infant model 16 June 2021 | By Victoria Rees (Drug Target Review) Two groups of infant rhesus macaques received one of two potential COVID-19 vaccines, which were shown to elicit high levels of neutralising antibodies.
news Scientists find evidence that SARS-CoV-2 infects cells in mouth 26 March 2021 | By Victoria Rees (Drug Target Review) Researchers have shown that SARS-CoV-2 infects mouth cells, which could inform the development of treatments against the oral symptoms of COVID-19.
news Antibody effector functions are key to combatting COVID-19, finds study 23 November 2020 | By Hannah Balfour (Drug Target Review) Rodent studies show that using antibodies with different targets and modes of action in combination is more effective at preventing and treating COVID-19.
news EIDD-2801 shows efficacy against COVID-19 in human cells and mice 7 April 2020 | By Hannah Balfour (Drug Target Review) Collaborators have shown that the broad spectrum oral antiviral EIDD-2801 could be a potential prophylactic or therapeutic for COVID-19 and other coronaviruses.
news Newly engineered peptide shows long-acting efficacy against HIV 6 December 2019 | By Victoria Rees (Drug Target Review) Researchers have developed a novel peptide with a prolonged half-life that has demonstrated success in rhesus monkeys and mice for inhibiting HIV infections.
news Researchers identify novel signalling systems in cells 1 November 2019 | By Victoria Rees (Drug Target Review) A study has revealed five new signalling processes in GPCR receptors on cells that have high therapeutic potential.
